Subramani, Pradeep A.
Vartak-Sharma, Neha
Sreekumar, Seetha
Mathur, Pallavi
Nayer, Bhavana
Dakhore, Sushrut
Basavanna, Sowmya K.
Kalappa, Devaiah M.
Krishnamurthy, Ramya V.
Mukhi, Benudhar
Mishra, Priyasha
Yoshida, Noriko
Ghosh, Susanta Kumar
Shandil, Radhakrishan
Narayanan, Shridhar
Campo, Brice
Hasegawa, Kouichi
Anvikar, Anupkumar R.
Valecha, Neena
Sundaramurthy, Varadharajan http://orcid.org/0000-0003-2562-8518
Funding for this research was provided by:
Medicines for Malaria Venture
Bill and Melinda Gates Foundation
NCBS-TIFR (Core support)
Article History
Received: 10 January 2020
Accepted: 12 June 2020
First Online: 22 June 2020
Ethics approval and consent to participate
: The procedures involving vivax patients was approved by Institutional Ethics Committee, National Institute of Malaria Research, Dwarka, New Delhi – 110077, registration number ECR/65/1nstlDLl2013. Approval document numbers are: ECR/NIMR/EC/2015/223 and ECR/NIMR/EC/2014/90.
: Not applicable.
: The authors declare that they have no competing interests.